ARCUTIS BIOTHERAPEUTICS, INC. Capital Expenditures
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) reported Capital Expenditures of $158.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $158.00K, a 102.56% increase year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $686.00K, a 379.72% increase from fiscal 2024.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $143.00K, a 66.59% decline from fiscal 2023.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $428.00K, a 28.53% increase from fiscal 2022.
- ARCUTIS BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $333.00K, a 66.53% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $158.00K 10-Q · filed 2026-08-05 | $158.00K derived: sum of 3 quarters · filed 2026-08-05 | $158.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $78.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $78.00K derived: sum of 3 quarters · filed 2026-08-05 | $686.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $78.00K derived: sum of 2 quarters · filed 2026-08-05 | $686.00K 10-Q · filed 2025-10-28 | $686.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $686.00K 10-Q · filed 2026-08-05 | $686.00K derived: sum of 3 quarters · filed 2026-08-05 | $829.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $608.00K 10-Q · filed 2026-05-06 | $608.00K derived: sum of 2 quarters · filed 2026-05-06 | $751.00K derived: sum of 3 quarters · filed 2026-05-06 | $751.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $143.00K derived: sum of 2 quarters · filed 2026-02-25 | $143.00K derived: sum of 3 quarters · filed 2026-02-25 | $143.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $143.00K derived: sum of 2 quarters · filed 2025-10-28 | $143.00K 10-Q · filed 2025-10-28 | $149.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $6.00K derived: sum of 3 quarters · filed 2026-02-25 | $70.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $6.00K derived: sum of 2 quarters · filed 2026-02-25 | $70.00K derived: sum of 3 quarters · filed 2026-02-25 | $346.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $70.00K derived: sum of 2 quarters · filed 2026-02-25 | $346.00K derived: sum of 3 quarters · filed 2026-02-25 | $428.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $340.00K derived: sum of 2 quarters · filed 2024-11-06 | $422.00K 10-Q · filed 2024-11-06 | $545.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $358.00K 10-Q · filed 2024-08-14 | $481.00K derived: sum of 3 quarters · filed 2025-02-25 | $487.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $82.00K 10-Q · filed 2024-05-14 | $205.00K derived: sum of 2 quarters · filed 2025-02-25 | $211.00K derived: sum of 3 quarters · filed 2025-02-25 | $291.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $129.00K derived: sum of 2 quarters · filed 2025-02-25 | $209.00K derived: sum of 3 quarters · filed 2025-02-25 | $333.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $86.00K derived: sum of 2 quarters · filed 2023-11-03 | $210.00K 10-Q · filed 2023-11-03 | $471.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $204.00K 10-Q · filed 2023-08-08 | $465.00K derived: sum of 3 quarters · filed 2024-02-27 | $602.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $124.00K 10-Q · filed 2023-05-09 | $385.00K derived: sum of 2 quarters · filed 2024-02-27 | $522.00K derived: sum of 3 quarters · filed 2024-02-27 | $565.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $398.00K derived: sum of 2 quarters · filed 2024-02-27 | $441.00K derived: sum of 3 quarters · filed 2024-02-27 | $995.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $180.00K derived: sum of 2 quarters · filed 2022-11-08 | $734.00K 10-Q · filed 2022-11-08 | $887.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $597.00K 10-Q · filed 2022-08-04 | $750.00K derived: sum of 3 quarters · filed 2023-02-28 | $860.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $554.00K 10-Q · filed 2022-05-05 | $707.00K derived: sum of 2 quarters · filed 2023-02-28 | $817.00K derived: sum of 3 quarters · filed 2023-02-28 | $834.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $263.00K derived: sum of 2 quarters · filed 2023-02-28 | $280.00K derived: sum of 3 quarters · filed 2023-02-28 | $321.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $127.00K derived: sum of 2 quarters · filed 2021-11-04 | $168.00K 10-Q · filed 2021-11-04 | $234.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $58.00K 10-Q · filed 2021-08-05 | $124.00K derived: sum of 3 quarters · filed 2022-02-22 | $128.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $41.00K 10-Q · filed 2021-05-06 | $107.00K derived: sum of 2 quarters · filed 2022-02-22 | $111.00K derived: sum of 3 quarters · filed 2022-02-22 | $153.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $70.00K derived: sum of 2 quarters · filed 2022-02-22 | $112.00K derived: sum of 3 quarters · filed 2022-02-22 | $295.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $46.00K derived: sum of 2 quarters · filed 2020-11-05 | $229.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $225.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $183.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |